The technology of immunotherapy, namely Provenge at this time, affords my patients 4 months increased MEDIAN (not average) survival time over the best known chemo regimen, without the morbidity of the side effects of chemotherapy.

FORBES: Survey Says Oncologists Not So Hot On Provenge